Invitro Evaluation of the Anti-Inflammatory Activity of Phloroglucinol and Alpha-lipoic acid

It was decided to test the anti-inflammatory activity of phloroglucinol and alpha-lipoic acid combined in order to evaluate the possibility of a synergistic effect in the battle against inflammation. Both the antioxidant alpha-lipoic acid and the naturally occurring phenolic compound phloroglucinol were investigated by researchers in order to ascertain whether or not they were capable of modulating inflammatory pathways and pathways in vitro. The effects of the combination on numerous inflammatory mediators, including cytokines (TNF-α, IL-1β, and IL-6), prostaglandin E2 (PGE2), and nitric oxide (NO) generation, were assessed by employing human peripheral blood mononuclear cells (PBMCs) that were cultivated. The results demonstrated that these pro-inflammatory markers were greatly reduced following the combination treatment, which may indicate that the combination treatment had a synergistic effect on reducing inflammation. Furthermore, the combination had a considerable impact on inhibiting the activation of nuclear factor-kappa B (NF-κB), which is an essential regulator of inflammation. These findings imply that the combination of phloroglucinol and alpha-lipoic acid could be a feasible therapy method for inflammatory disorders; nevertheless, additional in vivo research are required to establish the efficacy and safety of the combination.